Literature DB >> 15287243

Vernier acuity is selectively affected in infants and children with cortical visual impairment.

Ann M Skoczenski1, William V Good.   

Abstract

Cortical visual impairment (CVI) refers to bilateral impairment of vision that is usually due to damage occurring perinatally in the visual cortex and/or optic radiations. The most common cause of this damage is hypoxia, and other causes include encephalitis, meningitis, and trauma. Relatively little research has been done to quantify visual abilities in children with CVI. In the present study, we used an electrophysiological technique (visual evoked potentials) to measure two aspects of spatial vision in 35 infants and children with CVI (15 females, 20 males; mean age 3 years 6 months, SD 3 years 5 months; age range 4 months to 16 years). We measured each child's grating acuity (resolution for detecting high-contrast stripe patterns) and vernier acuity (resolution for localizing pattern elements). Performance on grating acuity and vernier acuity in individuals with CVI was compared with that of age-matched individuals with normal vision, and it was found that vernier acuity was relatively lower than grating acuity in children with CVI. Results support the theory that vernier acuity is cortically mediated, and suggest that vernier acuity is a more sensitive measure than grating acuity for quantifying vision deficits in patients with CVI.

Entities:  

Mesh:

Year:  2004        PMID: 15287243     DOI: 10.1017/s001216220400088x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  15 in total

Review 1.  Cortical visual impairment: new directions.

Authors:  William V Good
Journal:  Optom Vis Sci       Date:  2009-06       Impact factor: 1.973

2.  Quantitative fiber tracking of the optic radiation is correlated with visual-evoked potential amplitude in preterm infants.

Authors:  H C Glass; J I Berman; A M Norcia; E E Rogers; R G Henry; C Hou; A J Barkovich; W V Good
Journal:  AJNR Am J Neuroradiol       Date:  2010-05-06       Impact factor: 3.825

3.  Effect of Grade I and II intraventricular hemorrhage on visuocortical function in very low birth weight infants.

Authors:  Ashima Madan; Anthony M Norcia; Chuan Hou; Mark W Pettet; William V Good
Journal:  Seeing Perceiving       Date:  2012

4.  Visuocortical function in infants with a history of neonatal jaundice.

Authors:  Chuan Hou; Anthony M Norcia; Ashima Madan; William V Good
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-09-02       Impact factor: 4.799

5.  Visual cortical function in very low birth weight infants without retinal or cerebral pathology.

Authors:  Chuan Hou; Anthony M Norcia; Ashima Madan; Solina Tith; Rashi Agarwal; William V Good
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-25       Impact factor: 4.799

6.  Spatial contrast sensitivity vision loss in children with cortical visual impairment.

Authors:  William V Good; Chuan Hou; Anthony M Norcia
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-11-19       Impact factor: 4.799

7.  VEP vernier, VEP grating, and behavioral grating acuity in patients with cortical visual impairment.

Authors:  Tonya Watson; Deborah Orel-Bixler; Gunilla Haegerstrom-Portnoy
Journal:  Optom Vis Sci       Date:  2009-06       Impact factor: 1.973

Review 8.  VEP estimation of visual acuity: a systematic review.

Authors:  Ruth Hamilton; Michael Bach; Sven P Heinrich; Michael B Hoffmann; J Vernon Odom; Daphne L McCulloch; Dorothy A Thompson
Journal:  Doc Ophthalmol       Date:  2020-06-02       Impact factor: 2.379

9.  Evidence for visual compromise in preverbal children with orbital vascular birthmarks.

Authors:  William V Good; Chuan Hou; Ilona J Frieden; Anthony M Norcia
Journal:  Am J Ophthalmol       Date:  2009-02-04       Impact factor: 5.258

10.  Cerebral Visual Impairment Characterized by Abnormal Visual Orienting Behavior With Preserved Visual Cortical Activation.

Authors:  John P Kelly; James O Phillips; Russell P Saneto; Hedieh Khalatbari; Andrew Poliakov; Kristina Tarczy-Hornoch; Avery H Weiss
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-05-03       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.